The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Takeshi Tominaga

Breast Cancer Center

Toyosu Hospital

Showa University




Name/email consistency: high



  • Breast Cancer Center, Toyosu Hospital, Showa University, Tokyo, Japan. 2002 - 2010


  1. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial. Tominaga, T., Kimijima, I., Kimura, M., Takatsuka, Y., Takashima, S., Nomura, Y., Kasumi, F., Yamaguchi, A., Masuda, N., Noguchi, S., Eshima, N. Jpn. J. Clin. Oncol. (2010) [Pubmed]
  2. Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer. Tominaga, T., Takashima, S., Danno, M. Br. J. Surg (2004) [Pubmed]
  3. 1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial. Tominaga, T., Kimura, M., Asaga, T., Yoshida, M., Awane, H., Koyama, H., Takatsuka, Y., Mitsuyama, S., Ikeda, T., Ogita, M., Aoyama, H., Sano, M., Abe, R., Nishi, T., Wada, T., Danno, M., Toi, M., Takashima, S. Oncol. Rep. (2004) [Pubmed]
  4. Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. Tominaga, T., Adachi, I., Sasaki, Y., Tabei, T., Ikeda, T., Takatsuka, Y., Toi, M., Suwa, T., Ohashi, Y. Ann. Oncol. (2003) [Pubmed]
  5. Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery. Tominaga, T., Koyama, H., Toge, T., Miura, S., Sugimachi, K., Yamaguchi, S., Hirata, K., Monden, Y., Nomura, Y., Toi, M., Kimijima, I., Noguchi, S., Sonoo, H., Asaishi, K., Ikeda, T., Morimoto, T., Ota, J., Ohashi, Y., Abe, O. J. Clin. Oncol. (2003) [Pubmed]
  6. The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial. Tominaga, T., Toi, M., Abe, O., Ohashi, Y., Uchino, J., Hayasaka, H., Abe, R., Izuo, M., Enomoto, K., Watanabe, H., Yoshida, M., Taguchi, T., Koyama, H., Senoo, T., Toge, T., Monden, Y., Hattori, T., Nomura, Y., Sugimachi, K., Hirata, K., Nakazato, H., Miura, S., Morimoto, T., Asaishi, K., Kimijima, I., Ota, J., Sonoo, H., Yamaguchi, S. Int. J. Oncol. (2002) [Pubmed]
  7. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients. Tominaga, T., Toi, M., Ohashi, Y., Abe, O. Clin. Breast Cancer (2002) [Pubmed]
WikiGenes - Universities